Overall, our data suggest that Epo is involved in the regulation of angiogenic response occurring in MM through a direct effect on ECs, as well as on other cells of tumor microenvironment, including macrophages, as we have previously demonstrated [33]. The gene discussed is EPO; the disease is Miyoshi myopathy.